SCHEMBL30879486

CCCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)NC

nearest known ligand 0.52

Predicted protein targets (top 2)

	gene	UniProt	supporting neighbours	confidence
▸	GLP1R	P43220	19/20	0.52

▸	VIPR1	P32241	1/20	0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30483999	0.96	GLP1R (0.55)	GLP1RVIPR1
SCHEMBL30483991	0.94	GLP1R (0.54)	GLP1RVIPR1
SCHEMBL31066791	0.88	VIPR1 (0.55)	GLP1RVIPR1
SCHEMBL30495799	0.86	GLP1R (0.62)	GLP1R
SCHEMBL30912046	0.85	GLP1R (0.50)	GLP1RVIPR1
SCHEMBL30912049	0.85	GLP1R (0.53)	GLP1RVIPR1
SCHEMBL30262196	0.84	VIPR1 (0.65)	GLP1RVIPR1
SCHEMBL30432968	0.83	VIPR1 (0.59)	GLP1RVIPR1
SCHEMBL30433124	0.83	GLP1R (0.56)	GLP1RVIPR1
SCHEMBL30484003	0.82	VIPR1 (0.50)	GLP1RVIPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240181015-A1	EFFECT OF GHRH ANTAGONISTS IN DIABETES AND OBESITY	AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (US)	2024-06-06	—	—	US	disclosed